Acorah Software Products - Accounts Production 19.4.351 false true false true No description of principal activity 23 December 2024 31 December 2025 31 December 2025 SC832558 Dr Orwa Falah iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure SC832558 2024-12-22 SC832558 2025-12-31 SC832558 2024-12-23 2025-12-31 SC832558 frs-core:CurrentFinancialInstruments 2025-12-31 SC832558 frs-bus:PrivateLimitedCompanyLtd 2024-12-23 2025-12-31 SC832558 frs-bus:FilletedAccounts 2024-12-23 2025-12-31 SC832558 frs-bus:Micro-entities 2024-12-23 2025-12-31 SC832558 frs-bus:AuditExempt-NoAccountantsReport 2024-12-23 2025-12-31 SC832558 frs-bus:Director1 2024-12-23 2025-12-31
Registered number: SC832558
Edinburgh Aortic Summit Limited
Unaudited Financial Statements
For the Period 23 December 2024 to 31 December 2025
Accountax
Balance Sheet
Registered number: SC832558
31 December 2025
£
Current assets 7,329
Creditors: Amounts Falling Due Within One Year (5,689 )
NET CURRENT ASSETS 1,640
TOTAL ASSETS LESS CURRENT LIABILITIES 1,640
NET ASSETS 1,640
CAPITAL AND RESERVES 1,640

Notes

1. General Information
Edinburgh Aortic Summit Limited is a private company, limited by shares, incorporated in Scotland, registered number SC832558 . The registered office is 20/3 East Suffolk Park, Edinburgh, EH16 5PN.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Orwa Falah
Director
23/09/2026